Drug maker found liable despite FDA warning label

被引：0
|
作者：
机构：
来源：
Nature | 2009年 / 458卷 / 7235期
关键词：
D O I：
10.1038/458137c
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：137 / 137
相关论文
共 50 条
  • [21] Children's Exposure to Testosterone Gel Spurs FDA to Order Boxed Label Warning
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (23): : 2428 - 2428
  • [22] Why the food and drug administration changed the warning label for hetastarch
    Haynes, GR
    Havidich, JE
    Payne, KJ
    ANESTHESIOLOGY, 2004, 101 (02) : 560 - 561
  • [23] US high court to hear drug warning label dispute
    Hess, Glenn
    CHEMICAL & ENGINEERING NEWS, 2019, 97 (01) : 15 - 15
  • [24] New Alzheimer's drug clears FDA advisory vote despite unknowns
    Couzin-Frankel, Jennifer
    SCIENCE, 2024, 384 (6701) : 1164 - 1165
  • [25] FDA approves controversial Alzheimer's drug despite uncertainty over effectiveness
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [26] Accuracy of primary care medical providers' understanding of the FDA black box warning label for antidepressants
    Cordero, Liliana
    Rudd, M. David
    Bryan, Craig J.
    Corso, Kent A.
    PRIMARY CARE & COMMUNITY PSYCHIATRY, 2008, 13 (03) : 109 - 114
  • [27] Youth Exposure and Response to the FDA Health Warning Label on Electronic Cigarettes Packaging: Policy Implications
    Asfar, Taghrid
    Oluwole, Olusanya J.
    Pan, Yue
    Casas, Alejandra
    Garayua, Adriana Maite Hernandez
    Schmidt, Michael
    Noar, Seth M.
    NICOTINE & TOBACCO RESEARCH, 2024, 26 (02) : 151 - 160
  • [28] FDA Warning: Remove Drug Patches Before MRI to Prevent Burns to Skin
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (13): : 1328 - 1328
  • [29] FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone
    Cohen, Barbara R.
    Mahoney, Karen M.
    Baro, Elande
    Squire, Claudia
    Beck, Melissa
    Travis, Sara
    Pike-McCrudden, Amanda
    Izem, Rima
    Woodcock, Janet
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2129 - 2136
  • [30] FDA Regulation of Off-label Drug Promotion Under Attack
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Avorn, Jerry
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
12345